Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Surg. Jun 27, 2013; 5(6): 178-186
Published online Jun 27, 2013. doi: 10.4240/wjgs.v5.i6.178
Published online Jun 27, 2013. doi: 10.4240/wjgs.v5.i6.178
Figure 1 Kaplan-Meier survival of treatment groups.
A: Median survival (MS) for all patients in overall cohort was 6 mo; B: MS was highest for surgical patients, with an MS of 23 mo, compared to 9 mo and 8 mo for chemotherapy (chemo) and chemoradiation groups, respectively; C: Surgery alone patients had the highest survival (MS 28 mo), with MS of 18 and 22 mo for the adjuvant chemotherapy and adjuvant chemoradiation groups, respectively. CSP: Cancer Surveillance Program.
- Citation: Arrington AK, Nelson RA, Falor A, Luu C, Wiatrek RL, Fakih M, Singh G, Kim J. Impact of medical and surgical intervention on survival in patients with cholangiocarcinoma. World J Gastrointest Surg 2013; 5(6): 178-186
- URL: https://www.wjgnet.com/1948-9366/full/v5/i6/178.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v5.i6.178